(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

DERIVADO DE TETRAIDROISOQUINOLINA SUBSTITUÍDO, USO DO MESMO E COMPOSIÇÃO FARMACÊUTICA

Em ExigênciaInvention PatentPCT · EP2020068181

Application data

Number

112021022379

Type

Invention Patent

Filing

06/29/2020

Publication

03/08/2022

PCT

EP2020068181

Progress at the INPI

Technical opinion to answer
  1. Filing06/29/20
  2. Publication03/08/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/26/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

UCB BIOPHARMA SRL

BE

See this company's full portfolio

Inventors

A. V. (pessoa física)

BE

Technical data

Priority claims

EP

19183641.0 · 07/01/2019

Abstract

DERIVADO DE TETRAIDROISOQUINOLINA SUBSTITUÍDO COMO UM MODULADOR ALOSTERICO D1 POSITIVO.A presente invenção se refere a compostos de acordo com a fórmula (I), que são moduladores alostéricos positivos de D1 e, consequentemente, são benéficos como agentes farmacêuticos para o tratamento de doenças nas quais os receptores D1 desempenham um papel.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

05/26/2026

RPI 2890

Notificação de entrada na fase nacional - PCT

#1.3

03/08/2022

RPI 2670

Alteração de dados cadastrais

#1.1

11/23/2021

RPI 2655

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.